<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00955214</url>
  </required_header>
  <id_info>
    <org_study_id>SACRA1</org_study_id>
    <nct_id>NCT00955214</nct_id>
  </id_info>
  <brief_title>Small Coronary Artery Treated by TAXUS Liberté Registry in Japan</brief_title>
  <acronym>SACRA</acronym>
  <official_title>Impact of Paclitaxel-eluting Stent for Small Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Society for Advancement of Coronary Intervention Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Society for Advancement of Coronary Intervention Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The utilization of paclitaxel-eluting coronary stents in small vessel diseases is effective
      in reducing both repeat revascularization and major adverse cardiac events within two year
      follow-up. To evaluate the procedural, short and long term clinical outcomes of the Taxus
      Liberte™ Paclitaxel-Eluting Coronary Stent in small coronary arteries of ≤ 2.5 mm in the
      reference vessel diameter.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target lesion revascularization rate</measure>
    <time_frame>within 9months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>initial</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization rate</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization rate</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of MACE including MI due to stent thrombosis</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of MACE including MI due to stent thrombosis</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Stable Angina Pectoris</condition>
  <condition>Unstable Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>2.5mm Paclitaxel-eluting stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAXUS Liberté paclitaxel-eluting coronary stent system</intervention_name>
    <description>diameter is 2.5mm</description>
    <arm_group_label>2.5mm Paclitaxel-eluting stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥20 years and are able to undergo CABG

          2. Females who are not pregnant

          3. Patients who present with angina symptoms or myocardial ischemia

          4. Patients available for post-procedural observation and coronary angiography at 24
             months

          5. Patients who have signed patient informed consent

          6. Lesion which is eligible for only one 2.5mm paclitaxel-eluting stent

          7. De novo lesion or non-stented restenosed lesion

        Exclusion Criteria:

          1. Patients contraindicated for antiplatelet therapy or anticoagulant therapy

          2. Patients with significant allergic reaction to contrast medium

          3. Chronic total occlusion

          4. Lesion with TIMI0

          5. Lesion which is needed more than two stents

          6. Patients with chronic renal failure (SCr&gt;3.0mg/dl) -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenya Nasu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Toyohashi Heart Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yuji Oikawa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular institute hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Japanese red cross nagoya daiichi hospital</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <zip>4538511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Higashi Cardiovascular clinic</name>
      <address>
        <city>Toyohashi</city>
        <state>Aichi</state>
        <zip>4400836</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toyohashi Heart Center</name>
      <address>
        <city>Toyohashi</city>
        <state>Aichi</state>
        <zip>4418530</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kokura memorial hospital</name>
      <address>
        <city>Kitakyushu</city>
        <state>Fukuoka</state>
        <zip>8028555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hoshi general hospital</name>
      <address>
        <city>Koriyama</city>
        <state>Fukushima</state>
        <zip>9638501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southen tohoku research institute for neuroscience</name>
      <address>
        <city>Koriyama</city>
        <state>Fukushima</state>
        <zip>9638563</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gunma prefectural cardiovascular center</name>
      <address>
        <city>Maebashi</city>
        <state>Gunma</state>
        <zip>3710004</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asahikawa medical college hospital</name>
      <address>
        <city>Asahikawa</city>
        <state>Hokkaido</state>
        <zip>0788510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hakodate central general hospital</name>
      <address>
        <city>Hakodate</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shinko kakogawa hospital</name>
      <address>
        <city>Kakogawa</city>
        <state>Hyogo</state>
        <zip>6750115</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Okamoto general hospital</name>
      <address>
        <city>Uji</city>
        <state>Kyoto</state>
        <zip>6110025</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miyagi cardiovascular and respiratory center</name>
      <address>
        <city>Kurihara</city>
        <state>Miyagi</state>
        <zip>9894513</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rinku general medical center</name>
      <address>
        <city>Izumiotsu</city>
        <state>Osaka</state>
        <zip>5988577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shuwa general hospital</name>
      <address>
        <city>Kasukabe</city>
        <state>Saitama</state>
        <zip>3440035</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kasukabe chuo general hospital</name>
      <address>
        <city>Kasukabe</city>
        <state>Saitama</state>
        <zip>3440063</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kusatsu Heart Center</name>
      <address>
        <city>Kusatsu</city>
        <state>Shiga</state>
        <zip>5250014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ayase heart hospital</name>
      <address>
        <city>Adachi</city>
        <state>Tokyo</state>
        <zip>1200006</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Itabashi Chuo medical center</name>
      <address>
        <city>Itabashi</city>
        <state>Tokyo</state>
        <zip>1740051</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The cardiovascular institute hospital</name>
      <address>
        <city>Minato</city>
        <state>Tokyo</state>
        <zip>1060032</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo metropolitan police hospital</name>
      <address>
        <city>Naka</city>
        <state>Tokyo</state>
        <zip>1648541</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JR tokyo general hospital</name>
      <address>
        <city>Shibuya</city>
        <state>Tokyo</state>
        <zip>1518528</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo medical university hospital</name>
      <address>
        <city>Shinjuku</city>
        <state>Tokyo</state>
        <zip>1600023</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sakurabashi watanabe hospital</name>
      <address>
        <city>Osaka</city>
        <zip>5300001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <reference>
    <citation>Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MW, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2008 Dec;1(6):699-709. doi: 10.1016/j.jcin.2008.09.007.</citation>
    <PMID>19463387</PMID>
  </reference>
  <reference>
    <citation>Ahmed WH. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent. Expert Rev Med Devices. 2007 Mar;4(2):117-20. Review.</citation>
    <PMID>17359218</PMID>
  </reference>
  <reference>
    <citation>Elezi S, Dibra A, Mehilli J, Pache J, Wessely R, Schömig A, Kastrati A. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. J Am Coll Cardiol. 2006 Oct 3;48(7):1304-9. Epub 2006 Sep 12.</citation>
    <PMID>17010786</PMID>
  </reference>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2009</study_first_submitted>
  <study_first_submitted_qc>August 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2009</study_first_posted>
  <last_update_submitted>June 9, 2010</last_update_submitted>
  <last_update_submitted_qc>June 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kenya Nasu</name_title>
    <organization>Society for Advancement of Coronary Intervention Research</organization>
  </responsible_party>
  <keyword>TAXUS Liberté</keyword>
  <keyword>Small coronary artery disease</keyword>
  <keyword>Paclitaxel-eluting stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

